The global Optical Preclinical Imaging Market was valued at USD 4 billion in 2022, and it is expected to grow at a rapid CAGR of 4% during the forecast period. The increasing demand for non-invasive preclinical imaging techniques for drug research and development (RD) activities, personalized medicines, and the adoption of optical imaging modalities due to their ability to provide high-resolution and sensitivity images are the major factors driving market revenue growth.
Optical imaging modalities, such as Optical Coherence Tomography (OCT), Fluorescence Molecular Imaging (FMI), and Bioluminescence Imaging (BLI), are widely adopted for preclinical imaging due to their high resolution and sensitivity. Optical imaging is also safer than conventional imaging methods like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) because it is non-ionizing and non-invasive.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/6187
The creation of cutting-edge optical imaging technologies is another factor driving revenue growth. Manufacturers are investing in RD projects to develop the next generation of optical imaging systems with improved sensitivity, specificity, and resolution.
Key players in the Optical Preclinical Imaging Market:
- Bruker Corporation
- PerkinElmer, Inc.
- Aspect Imaging Ltd.
- Fujifilm Holdings Corporation
- Li-Cor Biosciences
- Miltenyi Biotec
- Trifoil Imaging Inc.
- Agilent Technologies Inc.
- Preclinical Imaging LLC
- Perceptive Instruments Ltd.
However, the high cost of optical preclinical imaging systems and the shortage of qualified personnel to operate them are major factors that could restrain market revenue growth. The lack of standardization in preclinical imaging protocols and the limited availability of optical imaging probes are other factors that could limit market growth.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6187
The market for optical preclinical imaging has been divided into segments for Computed Tomography (CT) imaging, Magnetic Resonance Imaging (MRI) imaging, Positron Emission Tomography (PET)/Single Photon Emission Computed Tomography (SPECT) imaging, multi-modal imaging, optical imaging, ultrasound imaging, photoacoustic imaging, reagents, and services. Optical imaging accounted for the largest revenue share in the global optical preclinical imaging market in 2022 due to the rising use of non-invasive and high-resolution imaging techniques in preclinical research.
Based on end-use, the global optical preclinical imaging market is segmented into biotech companies, pharmaceutical companies, and research institutes. The biotech companies segment is expected to account for the largest revenue share in the global market due to the increasing emphasis on personalized medicine and the rising prevalence of chronic diseases like cancer, cardiovascular diseases (CVD), and neurological disorders.
Government regulations play a crucial role in the optical preclinical imaging market. The U.S. Food Drug Administration (FDA) regulates all medical devices used for diagnosis or treatment of diseases, the European Medical Devices Regulation (MDR) requires all medical device manufacturers to provide detailed information on their products, the Japanese Ministry of Health, Labor and Welfare (MHLW) regulates optical preclinical imaging systems through its Good Manufacturing Practice (GMP) guidelines, the Central Drugs Standard Control Organization (CDSCO) regulates all medical devices used in clinical settings in India, and the Chinese government has implemented regulations for optical preclinical imaging systems, such as the Medical Device Quality Management System and the Medical Device Registration Regulation.
In preclinical research, optical preclinical imaging uses light to create images of biological tissues and organs in tiny animals. Optical imaging encompasses a number of methods, including near-infrared imaging, fluorescence imaging, and bioluminescence imaging, among others. Optical imaging techniques are in greater demand because they offer excellent spatial resolution, deep tissue penetration, and real-time imaging capabilities.
In conclusion, the global optical preclinical imaging market is expected to grow rapidly in the forecast period due to increasing demand for non-invasive preclinical imaging techniques, adoption of optical imaging modalities, and the rising prevalence of chronic diseases.
Request a customized copy of the report @
https://www.reportsanddata.com/request-customization-form/6175
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more reports…
https://tripyar.com/go.php?https://www.reportsanddata.com/report-detail/endometrial-ablation-market
